Several mechanisms have been proposed in endocrine resistance, including loss of ERα expression, gain-of-function mutations in ERα, crosstalk between ERα signaling and other pathways, cell cycle deregulation, and heterogeneity of tumor cell population [6,7,8,9,10,11]. Here, ESR1 is linked to neoplasm.